According to the FDA, generic drug companies must follow the same set of strict standards as name-branded drugs, including ensuring their products are bioequivalent and therapeutically equivalent to their name-brand counterparts. As a global leader in the production of generic drugs, our customer is very familiar with the standards they must follow when creating a new generic drug. They expend significant resources to test pending drugs before they are released to the market.
Download:
